Inventor · disambiguated record
Hong Du
Also filed as: DU HONG · DU HONG LIANG
19 granted patents·11 pending applications·193 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
30 records- 0194USD778117SBeverage bottleTHERMOS KK·Filed 2015·Granted Feb 7, 2017·62 cites·1 claims
- 0294USD778118SBeverage bottleTHERMOS KK·Filed 2015·Granted Feb 7, 2017·66 cites·1 claims
- 0386US6849257B2Lipid hydrolysis therapy for atherosclerosis and related diseasesCHILDREN S HOSPITAL RES FOUNDA·Filed 2001·Granted Feb 1, 2005·22 cites·29 claims
- 0485US8937056B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2013·Granted Jan 20, 2015·3 cites·14 claims
- 0584US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 0682US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 0777US7915306B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Mar 29, 2011·13 cites·92 claims
- 0872US8350059B2Intermediates and methods for making zearalenone macrolide analogsEISAI R&D MAN CO LTD·Filed 2008·Granted Jan 8, 2013·1 cites·24 claims
- 0969US11160783B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·18 claims
- 1068US10864255B2Lipid hydrolysis therapy for atherosclerosis and related diseasesCHILDRENS HOSPITAL MED CT·Filed 2017·Granted Dec 15, 2020·0 cites·3 claims
- 1167US11434246B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2021·Granted Sep 6, 2022·0 cites·30 claims
- 1267US8609640B2Multikinase inhibitors for use in the treatment of cancerAGOULNIK SERGEI·Filed 2008·Granted Dec 17, 2013·1 cites·15 claims
- 1366US10941148B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 9, 2021·0 cites·22 claims
- 1465US2024299483A1Targets and biomarkers for tumor microenvironmentsUNIV INDIANA TRUSTEES·Filed 2024·Application pending·0 cites
- 1565US2017296631A1Lipid hydrolysis therapy for atherosclerosis and related diseasesCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2017·Application pending·0 cites
- 1664US2025313456A1Extraction of Antigravity Hydrogen AtomsDU HONG·Filed 2024·Application pending·0 cites
- 1762US2004223960A1Gene-based lipid hydrolysis therapy for atherosclerosis and related diseasesFiled 2004·Application pending·0 cites
- 1861US2007264249A1Gene-based lipid hydrolysis therapy for atherosclerosis and related diseasesGRABOWSKI GREGORY A·Filed 2007·Application pending·0 cites
- 1959US10316040B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2016·Granted Jun 11, 2019·0 cites·20 claims
- 2059US2015182496A1Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2015·Application pending·0 cites
- 2158US2010239558A1Lipid Hydrolysis Therapy for Atherosclerosis and Related DiseasesGRABOWSKI GREGORY A·Filed 2010·Application pending·0 cites
- 2256US10857209B2Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatmentUNIV INDIANA RES & TECH CORP·Filed 2017·Granted Dec 8, 2020·0 cites·15 claims
- 2356US2013211103A1Intermediates and methods for making zearalenone macrolide analogsEISAI R&D MAN CO LTD·Filed 2013·Application pending·0 cites
- 2453US10782297B2Compositions and methods for diagnosing lung cancersUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Sep 22, 2020·0 cites·9 claims
- 2552US2009048333A1Zearalenone Macrolide Derivatives and Uses of the SameEISAI CO LTD·Filed 2008·Application pending·0 cites
- 2651US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 2750US12508259B2Pharmaceutical formulations containing NalbuphineHUMANWELL PHARMACEUTICAL US INC·Filed 2023·Granted Dec 30, 2025·0 cites·20 claims
- 2848US2013330317A1Methods for Treating Lysosomal Acid Lipase DeficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 2945US9279117B2Transgenic mouse conditionally expressing MMP12 for studying myelopoiesis, immunity and tumorigenesisYAN CONG·Filed 2012·Granted Mar 8, 2016·0 cites·7 claims
- 3039US8540905B2Chemiluminescent compositions and methods of making and using thereofLI WEIWEI·Filed 2011·Granted Sep 24, 2013·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Hong Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →